wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28081875-971706A8-734D-4CDD-89B6-9363F87037DB
Q28081875-971706A8-734D-4CDD-89B6-9363F87037DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28081875-971706A8-734D-4CDD-89B6-9363F87037DB
Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.
P2860
Q28081875-971706A8-734D-4CDD-89B6-9363F87037DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28081875-971706A8-734D-4CDD-89B6-9363F87037DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11213ef4f0bbd31c68d80f119ca1761ef3d0d612
P2860
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.